Skip to main content

Articles

Page 1 of 9

  1. Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...

    Authors: Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George and Nikolaus Marx

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35

    Content type: Commentary

    Published on:

  2. In Nigeria, there is a prevalence of aversive life circumstances that frequently assail the mental health and well-being of the citizens, mitigating the impact of which necessitates the institution of psychoth...

    Authors: Adeboye Olakunle Bamgboye, Ibrahim Adebayo Hassan, Yusuff Adebayo Adebisi, Rachael Oluwatoyosi Farayola and Theogene Uwizeyimana

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:34

    Content type: Commentary

    Published on:

  3. Drug use evaluation is a structured, methodological, and criteria-based drug assessment system that helps to evaluate the actual trend of drug use in a particular setting. If drug prescription practices are in...

    Authors: Bereket Bahiru Tefera, Melese Getachew and Bekalu Kebede

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:31

    Content type: Review

    Published on:

  4. Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has r...

    Authors: Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico and Claudio Jommi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:30

    Content type: Research

    Published on:

  5. Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policie...

    Authors: Bakani Mark Ncube, Admire Dube and Kim Ward

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:29

    Content type: Commentary

    Published on:

  6. Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system...

    Authors: Zuzaan Zulzaga, Erdenetuya Myagmarsuren, Herman J. Woerdenbag and Eugene P. van Puijenbroek

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:15

    Content type: Commentary

    Published on:

  7. Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims...

    Authors: Cindrel Tharumia Jagadeesan and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:28

    Content type: Review

    Published on:

  8. Self-care is one of the growing tasks of community pharmacy professionals. They are highly engaged in consultations in response to specific drug request (product-based presentation) or symptoms clients describ...

    Authors: Dawit Wondimsigegn, Berhanemeskel Woldegerima and Asefa Adimasu Taddese

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:26

    Content type: Research

    Published on:

  9. Increasingly, there has been recognition that siloed approaches focusing mainly on human health are ineffective for global antimicrobial resistance (AMR) containment efforts. The inherent complexities of AMR c...

    Authors: Mohan P. Joshi, Tamara Hafner, Gloria Twesigye, Antoine Ndiaye, Reuben Kiggundu, Negussu Mekonnen, Ndinda Kusu, Safoura Berthé, Edgar Peter Lusaya, Alphonse Acho, Robert Tuala Tuala, Ayasha Siddiqua, Henri Kaboré, Soukeyna Sadiya Aidara and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:27

    Content type: Research

    Published on:

  10. The COVID-19 pandemic has further strengthened the need for pharmacists to uptake non-traditional roles. Pharmacy practice in Saudi Arabia is emerging in recent years with greater policy emphasis on pharmacist...

    Authors: Eeman Mohammed, Saval Khanal, Zahraa Jalal, Ejaz Cheema, Mohammed H. Abutaleb and Vibhu Paudyal

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:25

    Content type: Research

    Published on:

  11. Minor ailments are defined as common, self-limiting, or uncomplicated conditions that may be diagnosed and managed without a medical intervention. Previous studies reported that pharmacists were able to help p...

    Authors: Mei Mei Tew, Ernieda Hatah, Faiz Arif, Muhammad Aqiff Abdul Wahid, Mohd Makmor-Bakry and Khairul Nizam Abdul Maulad

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:24

    Content type: Research

    Published on:

  12. The sustainable development goals were launched by the United Nations in 2015. Its fifth goal was describing the achievement of universal health coverage by 2030. This goal reaffirms the importance of investin...

    Authors: Banan Abdulrzaq Mukhalalati, Meram Mohamed Mahmoud Elsayed Ibrahim, Majdoleen Omar Al Alawneh, Ahmed Awaisu, Ian Bates and Lina Bader

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:22

    Content type: Research

    Published on:

  13. Achieving universal health coverage will require robust private sector engagement; however, as many low- and middle-income countries launch prepayment schemes to achieve universal health coverage, few are cove...

    Authors: Martha Embrey, Romuald Mbwasi, Elizabeth Shekalaghe, Jafary Liana, Suleiman Kimatta, Gasto Ignace, Angel Dillip and Tamara Hafner

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:21

    Content type: Research

    Published on:

  14. Inventory management is the heart of the supply system in improving availability of medicines, reducing the cost, and improving patient care quality. However, in the government facilities’ supply system, inven...

    Authors: Oliyad Kebede and Gizachew Tilahun

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:20

    Content type: Research

    Published on:

  15. Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of Americ...

    Authors: Ali Elbeddini and Rachel Gerochi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:19

    Content type: Research

    Published on:

  16. To strengthen medicines management capacity, including supply chain management, at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessmen...

    Authors: Denis Okidi Ladwar, Moses Nixon Sembatya, Nancy Miriam Amony, Morries Seru, Dennis Ross-Degnan, Laura Garabedian and Birna Trap

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:14

    Content type: Research

    Published on:

  17. Emergency department (ED) visits for high blood pressure are on the rise. Yet the majority of these patients are discharged home after their ED evaluation, particularly those who present following an elevated ...

    Authors: Ivona Mostarac and Clare L. Atzema

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:13

    Content type: Research

    Published on:

  18. The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and bes...

    Authors: Sabine Vogler, Nina Zimmermann, Zaheer-Ud-Din Babar, Reinhard Busse, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:18

    Content type: Commentary

    Published on:

  19. European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotio...

    Authors: Lisa Aufegger, Celine Yanar, Ara Darzi and Colin Bicknell

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:11

    Content type: Research

    Published on:

  20. The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of th...

    Authors: Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:17

    Content type: Commentary

    Published on:

  21. Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to...

    Authors: Gloria Twesigye, Tamara Hafner and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:16

    Content type: Commentary

    Published on:

  22. COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical...

    Authors: Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:12

    Content type: Commentary

    Published on:

  23. The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to...

    Authors: Ali Elbeddini, Sarah Almasalkhi, Thulasika Prabaharan, Cindy Tran, Mohamed Gazarin and Ahmed Elshahawi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:10

    Content type: Research

    Published on:

  24. Antimicrobial agents are among the most commonly prescribed drugs in pregnancy due to the increased susceptibility to infections during pregnancy. Antimicrobials can contribute to different maternal complicati...

    Authors: Mohamed A. Baraka, Lina Hussain AlLehaibi, Hind Nasser AlSuwaidan, Duaa Alsulaiman, Md. Ashraful Islam, Badriyah Shadid Alotaibi, Amany Alboghdadly, Ali H. Homoud, Fuad H. Al-Ghamdi, Mastour S. Al Ghamdi and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:9

    Content type: Research

    Published on:

  25. Research has shown that there is an increase in the global prevalence of asthma. Pharmacists are well positioned to screen and refer patients for better management of asthma. This study aimed to evaluate commu...

    Authors: Sanah Hasan, Lujain Al Oum and Nageeb AbdulGalil Hassan

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:8

    Content type: Research

    Published on:

  26. The pharmaceutical technology unit of the Geneva University Hospitals played a significant role in the fight against COVID-19 through four different missions: (1) providing enough hydroalcoholic solution at th...

    Authors: Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry and Lucie Bouchoud

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:7

    Content type: Letter to the editor

    Published on:

  27. Spontaneous reporting of adverse drug reactions (ADRs) is a method of monitoring the safety of drugs and is the basic strategy for the post-marketing surveillance of the suspected drugs. Despite its importance...

    Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Tayyaba Akram

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:5

    Content type: Research

    Published on:

  28. Changing demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives with...

    Authors: Nadia Farhanah Syafhan, Sayer Al Azzam, Steven D. Williams, Wendy Wilson, Jayne Brady, Peter Lawrence, Mark McCrudden, Mustafa Ahmed, Michael G. Scott, Glenda Fleming, Anita Hogg, Claire Scullin, Robert Horne, Harblas Ahir and James C. McElnay

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:4

    Content type: Research

    Published on:

  29. Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have the...

    Authors: Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim and Aidan Hollis

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:3

    Content type: Research

    Published on:

  30. Acute bronchiolitis is the leading cause of hospitalization in the pediatric population. The inappropriate prescription of antibiotics in acute bronchiolitis is associated with bacterial resistance, higher cos...

    Authors: Jefferson Antonio Buendía and John Edwin Feliciano-Alfonso

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:2

    Content type: Research

    Published on:

  31. The coronavirus disease 19 (COVID-19) pandemic is putting a huge strain on healthcare systems and is a turning point for the beginning of a global health crisis of an unprecedented condition. As such, the prov...

    Authors: Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa and Sultan Suleman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:1

    Content type: Commentary

    Published on:

  32. When the first wave of COVID-19 hit in March 2020, health care professionals across Canada were challenged to quickly and efficiently adapt to change their work practices in these unprecedented times. Pharmacy...

    Authors: Ali Elbeddini, Amy Botross, Rachel Gerochi, Mohamed Gazarin and Ahmed Elshahawi

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:76

    Content type: Commentary

    Published on:

  33. The digitalization of health and medicine and the growing availability of electronic health records (EHRs) has encouraged healthcare professionals and clinical researchers to adopt cutting-edge methodologies i...

    Authors: Carlos Del Rio-Bermudez, Ignacio H. Medrano, Laura Yebes and Jose Luis Poveda

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:75

    Content type: Commentary

    Published on:

  34. In Lebanon, difficulties in accessing medications are due to two main barriers, mainly: high cost and the lack of medication safety, related to poor-quality (irrational) prescription and use. The objective of ...

    Authors: Aline Hajj, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:70

    Content type: Short report

    Published on:

  35. The coronavirus disease 19 (COVID-19) is rapidly spreading across the world. Pharmacy services play a vital role in public health in preventing and containing the COVID-19 pandemic. All over the world, especia...

    Authors: Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza and Umer Ali

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:74

    Content type: Commentary

    Published on:

  36. Smoking cessation pharmacotherapies (SCPs) have been established as cost-effective for the treatment of tobacco use disorder across a variety of settings. In Jordan, a resource-constrained country where smokin...

    Authors: Saba Madae’en, Nour Obeidat and Mohammad Adeinat

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:65

    Content type: Policy analysis

    Published on:

  37. Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO us...

    Authors: Wayne Jones, Lenka Vojtila, Paul Kurdyak and Benedikt Fischer

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:68

    Content type: Short report

    Published on:

  38. The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries acr...

    Authors: Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:72

    Content type: Research

    Published on:

  39. Medical products are an integral and pivotal part of health care delivery. They need to be available, affordable and quality-assured. The SADC region is prone to threats arising from the availability and use o...

    Authors: Stanislav Kniazkov, Sakhile Dube-Mwedzi and Jean-Baptiste Nikiema

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:71

    Content type: Review

    Published on:

  40. Little is known about how much public payers spend on orphan medicines. This study aimed at identifying information on orphan medicine expenditure incurred by public payers that was published in literature glo...

    Authors: Margit Gombocz and Sabine Vogler

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:66

    Content type: Research

    Published on:

  41. A dispensing error can be defined as an inconsistency between the drug prescribed and drug dispensed to a patient. These errors can lead to ineffective and sometimes unwanted pharmaceutical outcomes. Dispensin...

    Authors: Sandeep Maharaj, Adrian Brahim, Horry Brown, Danielle Budraj, Vatalie Caesar, Anyse Calder, Deisha Carr, Dion Castillo, Kevin Cedeno and Manthan D. Janodia

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:67

    Content type: Research

    Published on:

  42. Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for...

    Authors: Colin Whaley, Ashley Bancsi, Joanne Man-Wai Ho, Catherine M. Burns and Kelly Grindrod

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:63

    Content type: Research

    Published on:

  43. Antibiotic resistance (ABX-R) is alarming in lower/middle-income countries (LMICs). Nonadherence to antibiotic guidelines and inappropriate prescribing are significant contributing factors to ABX-R. This study...

    Authors: Kashif Hussain, Muhammad Faisal Khan, Gul Ambreen, Syed Shamim Raza, Seema Irfan, Kiren Habib and Hasnain Zafar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:69

    Content type: Research

    Published on:

  44. Access to quality-assured, safe and efficacious medical products is fundamental for Universal Health Coverage and attaining Sustainable Development Goal 3: Ensure Healthy Lives and Well-being for All. To guara...

    Authors: S. Dube-Mwedzi, S. Kniazkov, J. B. Nikiema, O. M. J. Kasilo, A. Fortin, P. Tumusiime, G. N. Mahlangu and M. Ndomondo-Sigonda

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:64

    Content type: Review

    Published on:

  45. Due to a liberalisation reform in 2009, the availability of over-the-counter (OTC) analgesics has increased significantly in the Swedish market over the past decade. With the increasing number of generic produ...

    Authors: Helle Håkonsen, Maria Wängberg, Dina Alani and Tove Hedenrud

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:60

    Content type: Research

    Published on:

Annual Journal Metrics

\